Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2007 4
2009 1
2011 1
2013 2
2014 2
2016 1
2017 2
2018 1
2019 4
2020 3
2021 2
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.
Handley KF, Sims TT, Bateman NW, Glassman D, Foster KI, Lee S, Yao J, Yao H, Fellman BM, Liu J, Lu Z, Conrads KA, Hood BL, Barakat W, Zhao L, Zhang J, Westin SN, Celestino J, Rangel KM, Badal S, Pereira I, Ram PT, Maxwell GL, Eberlin LS, Futreal PA, Bast RC Jr, Fleming ND, Conrads TP, Sood AK. Handley KF, et al. Among authors: celestino j. JAMA Netw Open. 2022 Oct 3;5(10):e2236626. doi: 10.1001/jamanetworkopen.2022.36626. JAMA Netw Open. 2022. PMID: 36239936 Free PMC article.
Normal Risk Ovarian Screening Study: 21-Year Update.
Han CY, Lu KH, Corrigan G, Perez A, Kohring SD, Celestino J, Bedi D, Bedia E, Bevers T, Boruta D, Carlson M, Holman L, Leeds L, Mathews C, McCann G, Moore RG, Schlumbrecht M, Slomovitz B, Tobias D, Williams-Brown Y, Bevers MW, Liu J, Gornet TG, Handy BC, Lu Z, Bedia JS, Skates SJ, Bast RC Jr. Han CY, et al. Among authors: celestino j. J Clin Oncol. 2024 Apr 1;42(10):1102-1109. doi: 10.1200/JCO.23.00141. Epub 2024 Jan 9. J Clin Oncol. 2024. PMID: 38194613
Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors.
Khlebus E, Vuttaradhi VK, Welte T, Khurana N, Celestino J, Beird HC, Gumbs C, Little L, Legarreta AF, Fellman BM, Nguyen T, Lawson B, Ferri-Borgogno S, Mok SC, Broaddus RR, Gershenson DM, Futreal PA, Hillman RT. Khlebus E, et al. Among authors: celestino j. Mol Cancer Res. 2023 May 1;21(5):483-494. doi: 10.1158/1541-7786.MCR-22-0623. Mol Cancer Res. 2023. PMID: 37068116 Free PMC article.
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.
Wong KK, Bateman NW, Ng CW, Tsang YTM, Sun CS, Celestino J, Nguyen TV, Malpica A, Hillman RT, Zhang J, Futreal PA, Rojas C, Conrads KA, Hood BL, Dalgard CL, Wilkerson MD, Phippen NT, Conrads TP, Maxwell GL, Sood AK, Gershenson DM. Wong KK, et al. Among authors: celestino j. J Transl Med. 2022 Dec 17;20(1):606. doi: 10.1186/s12967-022-03820-x. J Transl Med. 2022. PMID: 36528667 Free PMC article.
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C, Bedia JS, Yang WL, Hawley SJ, Bergan L, Hopper M, Celestino J, Guo J, Gornet TG, Soosaipillai A, Yang H, Doskocil SD, Lokshin AE, Handy BC, Diamandis EP, Moore RG, Lu KH, Lu Z, Anderson KS, Drescher CW, Skates SJ, Bast RC Jr. Young Han C, et al. Among authors: celestino j. Br J Cancer. 2024 Mar;130(5):861-868. doi: 10.1038/s41416-023-02560-z. Epub 2024 Jan 9. Br J Cancer. 2024. PMID: 38195887 Free PMC article.
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses.
Irajizad E, Han CY, Celestino J, Wu R, Murage E, Spencer R, Dennison JB, Vykoukal J, Long JP, Do KA, Drescher C, Lu K, Lu Z, Bast RC, Hanash S, Fahrmann JF. Irajizad E, et al. Among authors: celestino j. Clin Cancer Res. 2022 Nov 1;28(21):4669-4676. doi: 10.1158/1078-0432.CCR-22-1113. Clin Cancer Res. 2022. PMID: 36037307 Free PMC article.
Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer.
Zhao L, Corvigno S, Ma S, Celestino J, Fleming ND, Hajek RA, Lankenau Ahumada A, Jennings NB, Thompson EJ, Tang H, Westin SN, Jazaeri AA, Zhang J, Futreal PA, Sood AK, Lee S. Zhao L, et al. Among authors: celestino j. Cancers (Basel). 2022 Jul 23;14(15):3589. doi: 10.3390/cancers14153589. Cancers (Basel). 2022. PMID: 35892848 Free PMC article.
Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications.
Melendez B, Shah S, Jiang Y, Dottino J, Watson E, Pearce H, Borthwick M, Schmandt RE, Zhang Q, Cumpian K, Celestino J, Fellman B, Yuan Y, Lu KH, Mikos AG, Yates MS. Melendez B, et al. Among authors: celestino j. J Control Release. 2021 Nov 10;339:521-530. doi: 10.1016/j.jconrel.2021.10.008. Epub 2021 Oct 12. J Control Release. 2021. PMID: 34648891 Free PMC article.
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.
Lee S, Zhao L, Rojas C, Bateman NW, Yao H, Lara OD, Celestino J, Morgan MB, Nguyen TV, Conrads KA, Rangel KM, Dood RL, Hajek RA, Fawcett GL, Chu RA, Wilson K, Loffredo JL, Viollet C, Jazaeri AA, Dalgard CL, Mao X, Song X, Zhou M, Hood BL, Banskota N, Wilkerson MD, Te J, Soltis AR, Roman K, Dunn A, Cordover D, Eterovic AK, Liu J, Burks JK, Baggerly KA, Fleming ND, Lu KH, Westin SN, Coleman RL, Mills GB, Casablanca Y, Zhang J, Conrads TP, Maxwell GL, Futreal PA, Sood AK. Lee S, et al. Among authors: celestino j. Cell Rep. 2020 Apr 14;31(2):107502. doi: 10.1016/j.celrep.2020.03.066. Cell Rep. 2020. PMID: 32294438 Free PMC article.
A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer.
Fahrmann JF, Irajizad E, Kobayashi M, Vykoukal J, Dennison JB, Murage E, Wu R, Long JP, Do KA, Celestino J, Lu KH, Lu Z, Bast RC, Hanash S. Fahrmann JF, et al. Among authors: celestino j. Cancers (Basel). 2021 Feb 22;13(4):913. doi: 10.3390/cancers13040913. Cancers (Basel). 2021. PMID: 33671595 Free PMC article.
33 results